Search Results
Search for other papers by Fiona Roberts in
Google Scholar
PubMed
Search for other papers by Greg Markby in
Google Scholar
PubMed
Search for other papers by Scott Dillon in
Google Scholar
PubMed
Search for other papers by Colin Farquharson in
Google Scholar
PubMed
Search for other papers by Vicky E MacRae in
Google Scholar
PubMed
. 1996 , Kirsch et al. 1997 , Nielsen et al. 2001 , Yoshiko et al. 2007 , Golub 2009 , Bourgine et al. 2011 ). Metabolic syndrome Metabolic syndrome is a global epidemic, with rates increasing alarmingly across both developed and
Search for other papers by Christine A Beamish in
Google Scholar
PubMed
Search for other papers by Yoon K Lee in
Google Scholar
PubMed
Search for other papers by A Osama Gaber in
Google Scholar
PubMed
Search for other papers by Priyanka Chanana in
Google Scholar
PubMed
Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas, USA
Search for other papers by Edward A Graviss in
Google Scholar
PubMed
Department of Cell and Microbiology, Weill Cornell Medical College, New York, New York, USA
Department of Genetics, The University of Texas Anderson Cancer Center, Houston, Texas, USA
Search for other papers by Malgorzata Kloc in
Google Scholar
PubMed
Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by M Waleed Gaber in
Google Scholar
PubMed
Search for other papers by Willa A Hsueh in
Google Scholar
PubMed
Department of Cell and Microbiology, Weill Cornell Medical College, New York, New York, USA
Search for other papers by Omaima M Sabek in
Google Scholar
PubMed
Introduction The confluence of factors that characterize metabolic syndrome (MetS) are prevalent in the Western world and includes hypertension, abdominal obesity, elevated fasting glucose, insulin resistance (IR), elevated blood triglycerides
Search for other papers by G Boaventura in
Google Scholar
PubMed
Search for other papers by G Casimiro-Lopes in
Google Scholar
PubMed
Search for other papers by C C Pazos-Moura in
Google Scholar
PubMed
Search for other papers by E Oliveira in
Google Scholar
PubMed
Search for other papers by P C Lisboa in
Google Scholar
PubMed
Search for other papers by E G Moura in
Google Scholar
PubMed
resistance and an altered lipid profile) are similar to those of metabolic syndrome ( Moura et al . 2009 ). More recently, we obtained a similar profile in adult animals with a non-pharmacological model where a maternal bandage was used to cover the teats of
Search for other papers by Shelley Gorman in
Google Scholar
PubMed
School of Population Health, Curtin University, Perth, Australia
Search for other papers by Alexander N Larcombe in
Google Scholar
PubMed
Search for other papers by Hayley E Christian in
Google Scholar
PubMed
dysfunction. One increasingly important example of metabolic dysfunction is metabolic syndrome, a cluster of conditions (high blood pressure, high blood glucose, abdominal adiposity and hyperlipidaemia) that increase the risk of heart disease, stroke and
Search for other papers by K Alexander H Iwen in
Google Scholar
PubMed
Search for other papers by Oezge Senyaman in
Google Scholar
PubMed
Search for other papers by Arne Schwartz in
Google Scholar
PubMed
Search for other papers by Maren Drenckhan in
Google Scholar
PubMed
Search for other papers by Britta Meier in
Google Scholar
PubMed
Search for other papers by Dirk Hadaschik in
Google Scholar
PubMed
Search for other papers by Johannes Klein in
Google Scholar
PubMed
Introduction Obesity and insulin resistance are at the centre of the metabolic syndrome which is a major risk factor for the development of cardiovascular disease. There is growing evidence for an implication of adipose dysfunction critically
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Search for other papers by Qinkai Li in
Google Scholar
PubMed
Search for other papers by Weidong Yin in
Google Scholar
PubMed
Search for other papers by Manbo Cai in
Google Scholar
PubMed
Search for other papers by Yi Liu in
Google Scholar
PubMed
Search for other papers by Hongjie Hou in
Google Scholar
PubMed
Search for other papers by Qingyun Shen in
Google Scholar
PubMed
Search for other papers by Chi Zhang in
Google Scholar
PubMed
Search for other papers by Junxia Xiao in
Google Scholar
PubMed
Search for other papers by Xiaobo Hu in
Google Scholar
PubMed
Search for other papers by Qishisan Wu in
Google Scholar
PubMed
Search for other papers by Makoto Funaki in
Google Scholar
PubMed
Search for other papers by Yutaka Nakaya in
Google Scholar
PubMed
Introduction The metabolic syndrome (syndrome X) refers to the aggregation of a cluster of risk factors, including insulin resistance/hyperinsulinemia and dyslipidemia (increased low-density lipoprotein cholesterol (LDL-C), and depressed high
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Victor P Bilan in
Google Scholar
PubMed
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Eman M Salah in
Google Scholar
PubMed
Search for other papers by Sheldon Bastacky in
Google Scholar
PubMed
Search for other papers by Huw B Jones in
Google Scholar
PubMed
Search for other papers by Rachel M Mayers in
Google Scholar
PubMed
Search for other papers by Bradley Zinker in
Google Scholar
PubMed
Search for other papers by Simon M Poucher in
Google Scholar
PubMed
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Stevan P Tofovic in
Google Scholar
PubMed
pathways of DN to be identified, it does not share primary features of metabolic syndrome: insulin resistance/hyperinsulinemia, obesity, and hypertension. Furthermore, STZ rats develop mild hyperlipidemia and are resistant to development of nephropathy
Search for other papers by Lyle Wiemerslage in
Google Scholar
PubMed
Search for other papers by Priya A Gohel in
Google Scholar
PubMed
Search for other papers by Giulia Maestri in
Google Scholar
PubMed
Search for other papers by Torfi G Hilmarsson in
Google Scholar
PubMed
Search for other papers by Michel Mickael in
Google Scholar
PubMed
Search for other papers by Robert Fredriksson in
Google Scholar
PubMed
Search for other papers by Michael J Williams in
Google Scholar
PubMed
Search for other papers by Helgi B Schiöth in
Google Scholar
PubMed
with the Tukey’s honestly significant difference correction. Data are reported as mean±1 s.e.m. Results TMEM18 appears to regulate metabolic syndrome via effects on insulin To find clues for TMEM18 ’s relationship with obesity, we
Search for other papers by Hong-Yo Kang in
Google Scholar
PubMed
current knowledge of the metabolic and vascular actions of testosterone in these disorders – specifically, how testosterone deficiency contributes to insulin resistance, metabolic syndrome, type 2 diabetes ( Kelly & Jones 2013 a ), and cardiovascular
Search for other papers by Harman S Mattu in
Google Scholar
PubMed
Search for other papers by Harpal S Randeva in
Google Scholar
PubMed
nutrition) have been shown to interact (including through metabolic syndrome, MetS) and contribute to CVD. White adipose tissue (WAT) has been identified as a metabolically active endocrine organ that affects a plethora of body functions including energy and